FUSO PHARMACEUTICAL INDUSTRIES financial statements, including revenue, expenses, and profit
The total revenue of 4538 for the last quarter is 16.92 B JPY, and it's 11.93% higher compared to the previous quarter. The net income of Q3 24 is 867.00 M JPY.